Clinical Trials Logo

Filter by:
NCT ID: NCT05330390 Enrolling by invitation - Epilepsy Clinical Trials

Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease

Start date: April 4, 2022
Phase:
Study type: Observational

The individualized drug delivery system of levetiracetam based on population pharmacokinetics and quantitative pharmacology model in patients with epilepsy complicated by diabetic kidney disease was established. To clarify the clinical feasibility of model-based individualized drug administration scheme.

NCT ID: NCT05320848 Enrolling by invitation - Clinical trials for Cardiac Rehabilitation

Value of Cardiac Rehabilitation on the Treatment of Cardiovascular Disease

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Cardiac rehabilitation is a valuable treatment for patients with a broad spectrum of cardiac disease. Current guidelines support its use in patients after acute coronary syndrome, coronary artery bypass grafting, coronary stent placement, valve surgery, and stable chronic systolic heart failure. Its use in these conditions is supported by a robust body of research demonstrating improved clinical outcomes. Despite this evidence, cardiac rehabilitation referral and attendance remains low and interventions to increase its use need to be developed.

NCT ID: NCT05320133 Enrolling by invitation - Clinical trials for Helicobacter Pylori Infection

Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

Start date: June 20, 2022
Phase: N/A
Study type: Interventional

This study is to evaluate the efficacy and safety of the Jinghua Weikang Capsule (a Chinese patent medicine for peptic ulcer and gastritis) containing quadruple therapy (Jinghua Weikang Caplsule plus triple therpy) for eradicating Helicobacter pylori in IgA nephropathy.

NCT ID: NCT05311293 Enrolling by invitation - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis

Start date: November 1, 2021
Phase:
Study type: Observational

The research group intends to carry out a case-control study to recruit IBS-D patients with anxiety and depression symptoms, by collecting intestinal mucosa for single-cell transcriptome sequencing, collecting peripheral blood for proteomic analysis, the two groups and patient symptoms are associated, and then discover the characteristics of molecular level changes associated with brain-gut axis dysfunction, explore the pathophysiological mechanism of comorbid anxiety and depression and IBS, and discover potential targets for effective treatment. This project can help to construct the colonic single-cell map of IBS-D patients and explore the differentially expressed genes in the colon of IBS patients and their signaling pathways related to neuroregulation, providing an effective therapeutic target for the treatment of comorbid anxiety and depression and IBS.

NCT ID: NCT05303532 Enrolling by invitation - Cancer Clinical Trials

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab

ROSY-D
Start date: April 19, 2022
Phase: Phase 3
Study type: Interventional

The rationale of the ROSY-D study is to continue to provide study treatment for patients who have participated in a parent study with Durvalumab and who are continuing to derive clinical benefit from treatment at the end of such studies, as judged by the Investigator.

NCT ID: NCT05302661 Enrolling by invitation - Liver Cirrhosis Clinical Trials

Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis

Start date: February 19, 2022
Phase: N/A
Study type: Interventional

A prospective, randomized controlled study on whether re-education after discharge can reduce the rebleeding rate after endoscopic treatment of esophageal and gastric varices in patients with liver cirrhosis

NCT ID: NCT05293457 Enrolling by invitation - Clinical trials for Artificial Intelligence

AI-assisted Gastroscopic Varicose Vein Diagnosis

Start date: April 25, 2022
Phase:
Study type: Observational

Validation of the accuracy of AI in assisting gastroscopic varices diagnosis through a prospective multicenter study

NCT ID: NCT05290467 Enrolling by invitation - Antenatal Care Clinical Trials

Reduced-visit Antenatal Care Model

Start date: March 20, 2022
Phase: N/A
Study type: Interventional

Antenatal care (ANC) is a critical measure to reduce maternal and perinatal morbidity and mortality. However, there are issues of too many visits and cumbersome procedures of ANC in many maternity hospitals of China. In the past year, the COVID-19 pandemic has brought huge impacts on the health systems, but also gives a valuable chance to review healthcare delivery strategies. Reduced-visit antenatal care models combined with remote monitoring have been recommended and implemented at most hospitals in China during the pandemic, particularly for low-risk pregnant women. However, due to limited evaluations of the cost-effectiveness, policymakers remain confused on how to appropriately integrate online delivery strategies with routine models to improve ANC quality and efficiency sustainably at scale. This is a single-blind, randomized controlled trial, conducted among low-risk pregnant women at Peking University Third Hospital in Beijing, to evaluate the effectiveness, acceptability, and cost of a reduced-visit ANC model combined with online monitoring compared to the routine ANC model. Participants will be randomly assigned in a 1:1 ratio to receive 12 routine ANC visits or the new ANC model consist of 9 outpatient visits and three online services with remote monitoring on their weight, heart rate, blood pressure, urinary protein, blood glucose, and fetal movement. CSOG-recommended ANC services will be provided to all participants. According to the study objectives and hypotheses, the primary outcome is adverse maternal and perinatal outcomes for non-inferiority analysis, and the secondary outcomes are acceptability and cost for superiority analysis.

NCT ID: NCT05289362 Enrolling by invitation - Clinical trials for Pancreatitis, Chronic

Comparison of Efficacy of Basket and Balloon in the Removal of Pancreatic Duct Stones in Chronic Pancreatitis Under ERCP

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

This study will compare the efficacy of basket and balloon in the removal of pancreatic duct stones under ERCP.

NCT ID: NCT05282719 Enrolling by invitation - Clinical trials for Myelodysplastic/Myeloproliferative Neoplasms

Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults

Start date: April 2022
Phase: Phase 2
Study type: Interventional

To explore the efficacy of venetoclax combined with azacytidine in Myelodysplastic / myeloproliferative neoplasms(MDS/MPN), so as to improve the overall survival and treatment status of MDS/MPN patients.